15 March 2017 - Medibank won't join other health funds to explain soaring private health insurance premiums at a parliamentary inquiry despite being the biggest player in the market.
The private health fund insists it can't make it for Thursday's public hearings although other major players Bupa, HCF and NIB are preparing to front the Senate inquiry in Canberra.
A Medibank spokeswoman told AAP senior executive Andrew Wilson was unable to attend because of a prior commitment but was able to make himself available "on another occasion if the committee chooses".
It comes as the Federal Court this week hears allegations from the Australian Competition and Consumer Commission that Medibank misled and deceived its customers by secretly changing policies to boost its profits before becoming a public company in 2014, leaving patients with unexpected costs.